Screening methods for the identification of compounds capable of

Details Screening methods for the identification of compounds capable of Screening methods for the identification of compounds capable of

1997-10-07

1999-12-07

Scheiner, Laurie

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving virus or bacteriophage

4242301, 4242331, C12Q 170, A61K 39245, A61K 3923

Patent

active

059981318

ABSTRACT:
The present invention provides methods for screening potential anti-viral therapeutic agents by monitoring their ability to disrupt the interaction between the BAK protein and a viral protein.

REFERENCES:
Ameisen et al., "Cell dysfunction and depletion in AIDS: The programmed cell death hypothesis" Immunol. Today (1991) 12: 102-105.
Barr, "Expression of foreign genes in yeast" Transgenesis (1992) pp. 55-79.
Boise et al., "bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death" Cell (1993) 74: 597-608.
Chen-Levy et al., "The bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18) translocation" Mol. Cell Biol. (1989) 9: 701-710.
Chittenden et al., "Unduction of apoptosis by the Bcl-2 homologue Bak" Nature (1995) 347: 733-736.
Clearly et al., "Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobin transcript resulting from the t(14;18) translocation" Cell (1986) 47: 19-28.
Cohen et al., "Apoptosis and programmed cell death in immunity" Ann. Rev. Immunol. (1992) 10: 267-293.
Duke et al., "IL-2 addiction: Withdrawal of growth factor activates a suide program in dependent T Cells" Lymphokine Res. (1986) 5: 289-299.
Edgington, "Looking death in the eye: Apoptosis and cancer research" Biotech. (1993).
Farrow et al., "Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K" Nature (1995) 374: 731-733.
Feinberg et al., "A technique for radiolabeling DNA restriction endonuclease to high specific actiity" Anal. BIochem (1984) 137: 266-267.
Gerchenson et al., "Apoptosis: A different type of cell death" FASEB J. (1992) 6: 2450-2455.
Hickish et al., "Ultrastructural localization of BHRF1: An Epstein-Barr virus gene product which has homology with bcl-2" Cancer Research (1994) 54: 2808-2811.
Hockenbery et al., "Bcl-2 functions in an antioxidant pathway to prevent apoptosis" Cell (1993) 75: 241-251.
Jacobson et al., "Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA" Nature (1993) 361: 365-369.
Kanter et al., "Epidermal growth factor and tumor promoters prevent DNA fragmentation by different mechanisms" Biochem. Biophys. Res. Commun. (1984) 118: 392-399.
Kiefer et al., "Modulation of apoptosis by the widly distributed Bcl-2 homologue Bak" Nature (1995) 374: 736-739.
Kiefer et al., "Molecular cloning of a new human insulin-like growth factor binding protein" Biochem. Biophys. Res. Commun. (1991) 176: 219-225.
Kruman et al., "Apoptosis of Murine BW 5147 thymoma cells induced by dexamethasone and .gamma.-irradiation" J. Cell. Physiol. (1991) 148: 267-273.
Lehrach et al., "RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination" Biochem. (1977) 16: 4743-4751.
McDonnell et al., "Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18)" Nature (1991) 349: 254-256.
Monaghen et al., "Ultrastructural localization of bcl-2 protein" J. Histochem. Cytochem. (1992) 40: 1819-1825.
Oltvai et al., "Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death" Cell (1993) 74: 609-619.
Sanger et al., "DNA sequencing with chain-terminating inhibitors" Proc. Natl. Acad. Sci. USA (1977) 74: 5463-5467.
Sentman et al., "Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes" Cell (1991) 67: 879-888.
Sheppard et al, "The relationship between AIDS and immunologic intolerance" J. AIDS (1992) 5: 143-147.
Strasser, "Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship" Cell (1991) 67: 889-899.
Tarodi et al., "Epstein-Barr virus BHRF1 protein protects against cell death induced by DNA-damaging agents and heterologous viral infection" Virology (1994) 201: 404-407.
Thomas, "Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose" Proc. Natl. Acad. Sci. USA (1980) 77: 5201-5205.
Tomei et al., "Inhibition of radiation-induced apoptosis in vitro by tumor promoters" Biochem. BIophys. Res. Commun. (1988) 155: 324-331.
Tsujimoto et al., "Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation" Science (1984) 226: 1097-1099.
Veis et al., "Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented haid" Cell (1993) 75: 229-240.
Williams set al., "Molecular regulation of apoptosis: genetic controls on cell death" Cell (1993) 74: 777-779.
Wyllie, "Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation" Nature (1980) 284: 555-556.
Zapf et al., "Isolation from adult human serum of four insulin-like growth factor (IGF) binding proteins and molecular cloning of one of them that is increased by IGF I administration and in extrapancreatic tumor hypoglycemia" J. Biol. Chem. (1990) 265: 14892-14898.
Zhu et al., "Systemic gene expression after intravenous DNA delivery into adult mice" Science (1993) 261: 209-211.
Cheng et al., "A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak" Proc. Natl. Acad. Sci. USA (1977) 94: 690-694.
D'Sa-Eipper et al., "bfl-1, a bcl-2 homologue, suppresses p53-induced apoptosis and exhibits potent cooperative transforming activity" Cancer Research (1996) 56 (17): 3879-3882.
Henderson et al., "Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death" Proc. Natl. Acad. Sci. USA (1993) 90(18): 8479-8483.
Lewin, R., "When does homology mean something else?" Science (1987) 237: 1570.
Murray et al., "BCL-2 but not its Epstein-Barr virus-encoded homologue, BHRF1, is commonly expressed in posttransplantation lymphoproliferative disorders" Blood (1996) 87(2): 706-711.
Nava et al., "Herpesvirus saimiri encodes a functional homolog of the human bcl-2 oncogene" J. of Virology (1997) 71(5): 4118-4122.
Nicholas et al., "A single 13-kilobase divergent locus in the kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genome contains nine open reading frames that are homologous to or related to cellular proteins" J. of VIrology (1997) 71(3): 1963-1974.
Reeck et al., "`Homology` in proteins and nucleic acids: A terminology muddle and a way out of it" Cell (1987) 50: 667.
Sarid et al., "Kaposi's sarcoma-associated herpesvirus encodes a functional Bcl-2 homologue" Nature Medicine (1997) 3(3): 293-298.
Smith, C.A., "A novel viral homologue of Bcl-2 and Ced-9" Trends in Cell Biology (1995) 5(9):344.
Theodorakis et al., "Unmasking of a proliferation-restraining activity of the anit-apoptosis protein EBV BHRF1" Oncogene (1996) 12(8): 1707-1713.
Virgin IV, et al., "Complete sequence and genomic analysis of murine gammaherpesvirus 68" J. of Virology (1997) 71(8): 5894-5904.
Wylie, "Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation" Nature (1980) 284:555-556.
Sheppard et al., "The relathioship between AIDS and immunologic intolerance" J. AIDS (1992) 5:143-147.
Gerschenson et al., "Apoptosis: A different type of cell death" FASEB J. (1992) 6:2450-2455.
Cohen et al. "Apoptosis and programmed cell death in immunity" Ann. Rev. Immunol. (1992) 10:267-293.
Cleary et al., "Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobin transcript resulting from the t(14;18) translocation" Cell (1986) 47:19-28.
Strasser, "bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship" Cell (1991) 67:889-899.
Williams et al., "Molecular regulation of apoptosis: genetic controls on cell death" Cell (1993) 74:777-779.
Veis et al., "Bcl-2-deficient mice4 demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair" Cell (1993) 75:229-240.
Chen-Levy et al., "The bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18) translocation" Mol. Cell. Biol. (1989) 9:701-7

Affiliated with

Also associated with

Rating

Screening methods for the identification of compounds capable of does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Screening methods for the identification of compounds capable of, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Screening methods for the identification of compounds capable of will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-822300